Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/041910 stock hub

KOSDAQ/041910 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/041910is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
100.7B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/041910
In the news

Latest news · KOSDAQ/041910

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E89.5
P25 n/aP50 n/aP75 n/a
ROE0.8
P25 n/aP50 n/aP75 n/a
ROIC3.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/041910 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
204
Groups with data
11
Currency
KRW
Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
South Korea
Country code
KR
Employees
160
Employees Change
-9%
Employees Change Percent
-5.29
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
KRW 100.7B
Price
KRW 7,580
Price currency
KRW
Rev Per Employee
399,595,459.38x
Sic
2834
Symbol
kosdaq/041910
Website
https://www.polarisaipharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
0.98%
FCF yield
-4.66%
P/B ratio
0.82x
P/E ratio
89.48x
P/S ratio
1.57x
PE Ratio10 Y
26.24x
PE Ratio3 Y
20.01x
PE Ratio5 Y
21.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
4.94%
EBITDA Margin
9.04%
Gross margin
20.13%
Gross Profit
KRW 12.9B
Gross Profit Growth
-7.15%
Gross Profit Growth Q
-22.45%
Gross Profit Growth3 Y
1.86%
Gross Profit Growth5 Y
1.07%
Net Income
KRW 989.5M
Net Income Growth
-92.8%
Net Income Growth Q
-42.98%
Net Income Growth3 Y
-58.98%
Net Income Growth5 Y
-27.7%
Pretax Margin
0.4%
Profit Margin
1.55%
Profit Per Employee
KRW 6.2M
ROA
1.53
Roa5y
2.24
ROCE
2.52
ROE
0.82
Roe5y
9.41
ROIC
3.41
Roic5y
5.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
-9.7%
Cagr15y
4.62%
Cagr1y
33.71%
Cagr20y
2.32%
Cagr3y
-0.46%
Cagr5y
-8.36%
Div CAGR10
7.18%
Div CAGR3
0%
Div CAGR5
0%
EPS Growth
-92.8
EPS Growth Q
-42.98
EPS Growth3 Y
-59.44
EPS Growth5 Y
-27.64
Revenue Growth
8.69x
Revenue Growth Q
0.05x
Revenue Growth3 Y
13.54x
Revenue Growth5 Y
10.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
KRW 0.5
Assets
KRW 132.4B
Cash
KRW 29.1B
Current Assets
KRW 68.1B
Current Liabilities
KRW 7.1B
Debt
KRW 1B
Debt EBITDA
KRW 0.18
Debt Equity
KRW 0.01
Debt FCF
KRW -0.22
Equity
KRW 123.2B
Interest Coverage
144.6
Liabilities
KRW 9.2B
Long Term Assets
KRW 64.3B
Long Term Liabilities
KRW 2.1B
Net Cash
KRW 28.1B
Net Cash By Market Cap
KRW 27.86
Net Cash Growth
-38.12%
Net Debt EBITDA
KRW -4.85
Net Debt Equity
KRW -0.23
Tangible Book Value
KRW 122.4B
Tangible Book Value Per Share
KRW 10,477
WACC
7.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
9.62
Inventory Turnover
2.58
Net Working Capital
KRW 32.2B
Quick ratio
6.48
Working Capital
KRW 61B
Working Capital Turnover
KRW 0.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Dividend per share
KRW 0
Last Dividend
KRW 100
Payout Ratio
118.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-63.93%
1Y total return
33.69%
200-day SMA
6,710.2
3Y total return
-1.37%
50-day SMA
7,098.8
50-day SMA vs 200-day SMA
50over200
5Y total return
-35.37%
All Time High
41,950
All Time High Change
-81.93%
All Time High Date
2015-07-06
All Time Low
1,425.1
All Time Low Change
431.89%
All Time Low Date
2004-03-01
ATR
537.3
Beta
0.54
Beta1y
0.32
Beta2y
0.51
Ch YTD
21.67
High
8,240
High52
10,200
High52 Date
2026-03-16
High52ch
-25.69%
Low
7,400
Low52
5,620
Low52 Date
2025-05-08
Low52ch
34.88%
Ma50ch
6.78%
Price vs 200-day SMA
12.96%
RSI
59.71
RSI Monthly
54.13
RSI Weekly
58.13
Sharpe ratio
0.61x
Sortino ratio
1.42
Tr YTD
21.67
Tr15y
97.02%
Tr1m
11.8%
Tr1w
3.27%
Tr3m
17.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
KRW 3.2B
Operating Income Growth
-33.38
Operating Income Growth Q
-48.1
Operating Income Growth3 Y
-9.05
Operating Income Growth5 Y
-1.29
Operating margin
4.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
8,724,887%
Net Borrowing
-253,904,220
Shares Insiders
4.33%
Shares Institutions
0.05%
Shares Out
13,283,350
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
KRW -4.7B
Average Volume
1,408,125.05x
Bv Per Share
10,549.4
CAPEX
KRW -1.8B
Ch10y
-66.46
Ch15y
77.93
Ch1m
11.8
Ch1w
3.27
Ch1y
33.69
Ch20y
33.22
Ch3m
17.52
Ch3y
-2.82
Ch5y
-37.87
Ch6m
22.26
Change
0.53%
Change From Open
1.07
Close
7,540
Days Gap
-0.53
Depreciation Amortization
2,617,462,000
Dollar Volume
27,536,570,940
EBIT
KRW 3.2B
EBITDA
KRW 5.8B
EPS
KRW 84.72
F Score
3
FCF
KRW -4.7B
FCF Per Share
KRW -353
Financing CF
-1,421,904,820
Fiscal Year End
December
Founded
1,996
Graham Number
4484.23698
Graham Upside
-40.84
Income Tax
KRW -733.1M
Investing CF
-9,153,139,420
Is Primary Listing
1
Last Earnings Date
2025-03-21
Last Report Date
2022-09-30
Last Split Date
2005-05-09
Last Split Type
Forward
Lynch Fair Value
KRW 424
Lynch Upside
-94.41
Ma150
6,703
Ma150ch
13.08%
Ma20
7,078
Ma20ch
7.09%
Net CF
-13,469,521,750
Open
7,500
Position In Range
21.43
Ppne
31,616,610,810
Price Date
2026-05-08
Price EBITDA
KRW 17.43
Ptbv Ratio
0.82
Relative Volume
2.58x
Revenue
63,935,273,500x
Tax By Revenue
-1.15x
Tr20y
58.26%
Tr6m
22.26%
Volume
3,632,793
Z Score
8.93
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/041910 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/041910 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+33.7%
S&P 500 1Y: n/a
3Y total return
-1.4%
S&P 500 3Y: n/a
5Y total return
-35.4%
S&P 500 5Y: n/a
10Y total return
-63.9%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/041910?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+4.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

KOSDAQ/041910 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.7
Neutral momentum band
Price vs 200-day MA
+13.0%
50/200-day relationship not available
Beta (5Y)
0.54
Less volatile than the market
Sharpe ratio
0.61
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/041910

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/041910 stock rating?

kosdaq/041910 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/041910 analysis?

The full report lives at /stocks/kosdaq/041910/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/041910?

The latest report frames kosdaq/041910 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/041910 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.